Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep791 | Pituitary: clinical | ECE2015

Lung function tests in 109 acromegalic patients

Stormann Sylvere , Gutt Bodo , Roemmler-Zehrer Josefine , Bidlingmaier Martin , Schopohl Jochen , Angstwurm Matthias

Introduction: Acromegaly is a chronic disease that affects morphology and organ functions. These changes lead to clinically relevant comorbidities. Untreated acromegaly reduces life expectancy by 10 years, mostly due to cardiovascular events, malignancies and respiratory disorders. We present the results of a series of 109 acromegalic patients at a single institution.Methods: Lung function tests were performed under standardized conditions in patients wi...

ea0037ep922 | Thyroid cancer | ECE2015

Incidence of intrathyroid location of parathyroid glands and description of their characteristics compared to extrathyroid ones

Michalopoulos Nick , Margaritidou Efterpi , Kotidis Efstathios , Sapalidis Konstantinos , Kanellos Ioannis , Panayiotou Kalliopi Pazaitou

Introduction: Total thyroidectomy (TT) is a safe and effective operation. The most frequent complication after TT is hypoparathyroidism. Surgical trauma, devasculisation of parathyroid glands and inadvertent parathyroidectomy have been identified as the main causes resulting in postoperative hypocalcaemia. The objectives of this study are to investigate the incidence of intrathyroid parathyroid glands (ITPGs) in a large cohort and to clarify their histological characteristics....

ea0037ep950 | Thyroid (non-cancer) | ECE2015

Radioiodine treatment of Graves' disease: dose–response analysis

Cepkova Jitka , Svilias Ioannis , Krcalova Eva , Horacek Jiri

Introduction: Despite more than 60 years’ experience with radioactive iodine 131I (RAI) treatment of Graves’ disease (GD) about the most appropriate dosing regime is still controversial. The objective of our research was to analyse the outcome of RAI therapy in our cohort of patients.Methods: Retrospectively, we analysed 603 patients with GD (500 women and 103 men, mean age 51.5±12.7 years) treated with RAI. According to recomme...

ea0037ep974 | Thyroid (non-cancer) | ECE2015

Thyroid autoimmunity may effect on mean platelet volume

Kalan Isilay , Durmaz Senay Arikan , Yavuz Seyma , Carlioglu Ayse , Cosar Ramazan , Cifci Aydin

Aim: Mean platelet volume (MPV) is considered a new indicator of atherosclerosis. Activated platelets and subclinical inflammation predispose to create for atherosclerotic heart disease. Larger platelets are metabolically more active than smaller ones and have more protrombotic potential. We have recently demonstrated that MPV levels in Hashimoto’s patients tend to be higher than healthy controls even if in euthyroid state. In present study we aimed to investigate a relat...

ea0037ep1103 | Endocrine tumours | ECE2015

Morphological features and functional activity of parathyroid adenomas

Aleksandrov Yuri , Oralov Dmitryi , Pamputis Sergey

Study for morphological and hormonal changes in the parathyroid glands in 35 patients with primary hyperparathyroidism was carried out. Post-mortem material (five bodies) used to control. All patients had primary hyperparathyroidism and elevated levels of parathyroid hormone and ionized calcium in serum. Morphometric study evaluated the cellular structure (chief and oxyphil cells) and calculated the ratio of the basic elements of parathyroid cells (nucleus, cytoplasm) and stro...

ea0037ep1115 | Endocrine tumours | ECE2015

Multifocal insulinomas (insulinomatosis) in GLP-1-receptor PET/CT

Jenni Stefan , Antwi Kwadwo , Fani Melponemi , Wild Damian , Heye Tobias , Gloor Beat , Perren Aurel , Christ Emanuel

Introduction: Apart from occurring sporadically, insulinoma within the framework of multiple endocrine neoplasia 1 (MEN-1) is well known. The rare presence of multifocal insulinomas has recently been assigned a separate entity (insulinomatosis). The difficulty of localising insulinomas may be improved by GLP1-receptor imaging.Case report A 48-year-old woman had been treated for suspected epileptic seizures for 2 years (lamotrigine). During another such e...

ea0037ep1321 | Clinical Cases–Thyroid/Other | ECE2015

Can pericardial effusion be a manifestation of Graves' disease? An unusual case

Besis George , Kyriakakis Nikolaos , Premawardhana Lakdasa D

Introduction: Graves’ disease (GD) is associated with a number of cardiovascular complications, including rhythm disturbances, mitral valve prolapse, pulmonary hypertension and heart failure. Pericardial effusion in the context of GD has only been reported in a small number of cases.Case: A 59-year-old gentleman presented with a 3-day history of dyspnoea and pleuritic chest pain. He had a previous history of GD 8 months ago, pulmonary embolism (PE),...

ea0035p48 | Adrenal cortex | ECE2014

Retrospective analysis of adrenal ıncidentalomas: a single center experience

Akin Safak , Helvaci Nafiye , Dagdelen Selcuk , Yildiz Bulent Okan , Gurlek Alper , Erbas Tomris , Bayraktar Miyase

Background and aim: Incidentally discovered adrenal masses (adrenal incidentalomas (AI)), generally 1 cm or more in diameter, are mostly benign and asymptomatic and are often considered as nonfunctional tumors. The aim of this study was to perform the imaging characteristics, endocrinologic screening and histologic diagnoses of adrenal incidentaloma cases encountered in our institute.Methods: This retrospective evaluation of patients with AI includes 543...

ea0035p434 | Diabetes complications | ECE2014

The influence of maternal BMI and weight gain in gestational diabetes: results of the Portuguese population in 2011

Santos Maria Joana , Fernandes Vera , Pereira Maria Lopes , Marques Olinda

Background and aims: Maternal BMI and weight gain are associated with maternal and fetal complications in gestational diabetes (GD), but their relative contribution is not clearly defined. Our aim was to determine the influence of BMI and weight gain in the evolution of GD.Material and methods: Multicenter, retrospective study of women diagnosed with GD at the medical centers of the Portuguese Group for the Study of Diabetes and Pregnancy in 2011. We use...

ea0035p878 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

A case with macroprolactinemia and gigantomastia responding to cabergoline treatment

Dellal Fatma Dilek , Aydin Cevdet , Kaya Mina Gulfem , Ersoy Reyhan , Cakir Bekir

Macroprolactinemia is reportedly 10–25% in patients with hyperprolactinemia (1). Prolactin plays a major role in breast development (2). Macromastia, gigantomastia, breast hypertrophy are used interchangeably (3). Most authors conclude that gigantomastia cannot be treated medically and only resolves with surgical manoeuvres (4). We report a case with gigantomastia diagnosed with macroprolactinemia and treated with cabergolin.Case: A 44-year-old woma...